Access cutting-edge kidney transplant treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.
Access kidney transplant specialists in Richmond at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney transplant treatment provided free
This is a prospective, randomized multicenter trial of preemptive therapy (PET) vs. antiviral prophylaxis (AP) for prevention of cytomegalovirus (CMV) disease in adult D+R- kidney transplant recipients (KTR). Patients meeting study eligibility criteria and who have provided informed consent will be randomized (1:1) within 7 days of transplant to receive, in an open label design, either AP with valganciclovir 900 mg orally once daily or letermovir 480 mg orally once daily \[both dose adjusted per
Sponsor: University of California, San Francisco
Check if you qualify for this kidney transplant clinical trial in Richmond, VA
If you're searching for kidney transplant treatment options in Richmond, VA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.